Acalabrutinib

Status
Phase 2
Condition
COVID-19
Intervention Type
Oral Drug
Funder Type
Industry

Drug Details


Study Purpose

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >